Form 4: Oscar Health Director Acquires Deferred Stock Units in Lieu of Cash Retainer

Sentiment:

SEC Form 4 Filing


Director Jeffery H. Boyd acquired 4,285 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments.

Summary

  • On April 10, 2025, Jeffery H. Boyd, a director of Oscar Health, Inc., acquired 4,285 deferred stock units.
  • These units were received in lieu of cash retainer payments for service on the Issuer's board of directors, as elected under the Amended and Restated Deferred Compensation Plan for Directors.
  • The price of the deferred stock units was $12.25, based on the closing price of Oscar Health's Class A common stock on April 10, 2025.
  • Following the transaction, Boyd beneficially owns 57,207 deferred stock units.
  • The deferred stock units will be settled for cash or shares of Class A common stock within 45 days of termination of service, a change in control, death, or disability.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to director compensation. It's neutral in sentiment as it simply reports the acquisition of deferred stock units.

Positives

  • The director's decision to take deferred stock units instead of cash may signal confidence in the company's future performance.

Future Outlook

The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability.

Industry Context

Directors often receive stock-based compensation to align their interests with those of shareholders. This transaction is a standard practice in corporate governance.

Comparison to Industry Standards

  • Stock-based compensation for directors is a common practice across publicly traded companies, particularly in the healthcare sector.
  • Companies like UnitedHealth Group (UNH) and Anthem (ANTM) also utilize stock options and restricted stock units as part of their director compensation packages.
  • The specific amount and terms of the deferred stock units are likely benchmarked against peer companies to ensure competitive compensation for board members.

Stakeholder Impact

  • The transaction aligns the director's interests with shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

DateDescription
04/10/2025Date of transaction: Acquisition of deferred stock units.
04/14/2025Date of report filing.

Keywords

Oscar Health, Deferred Stock Units, Director, Form 4, Beneficial Ownership, OSCR, Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.